KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent Deferred Tax AssetsCurrent TaxesDividends payablesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pfizer (PFE) Accumulated Expenses (2016 - 2025)

Pfizer (PFE) has disclosed Accumulated Expenses for 17 consecutive years, with $3.6 billion as the latest value for Q4 2025.

  • On a quarterly basis, Accumulated Expenses fell 5.94% to $3.6 billion in Q4 2025 year-over-year; TTM through Dec 2025 was $3.6 billion, a 5.94% decrease, with the full-year FY2025 number at $3.6 billion, down 5.94% from a year prior.
  • Accumulated Expenses was $3.6 billion for Q4 2025 at Pfizer, up from $3.0 billion in the prior quarter.
  • In the past five years, Accumulated Expenses ranged from a high of $3.8 billion in Q4 2024 to a low of $2.0 billion in Q3 2023.
  • A 5-year average of $2.7 billion and a median of $2.6 billion in 2021 define the central range for Accumulated Expenses.
  • Peak YoY movement for Accumulated Expenses: dropped 18.52% in 2023, then surged 42.62% in 2024.
  • Pfizer's Accumulated Expenses stood at $3.3 billion in 2021, then rose by 2.25% to $3.4 billion in 2022, then dropped by 18.52% to $2.8 billion in 2023, then soared by 38.26% to $3.8 billion in 2024, then fell by 5.94% to $3.6 billion in 2025.
  • Per Business Quant, the three most recent readings for PFE's Accumulated Expenses are $3.6 billion (Q4 2025), $3.0 billion (Q3 2025), and $2.4 billion (Q2 2025).